Global AI In Clinical Trials Market Research Report 2026(Status and Outlook)
The AI in Clinical Trials market is experiencing significant growth and is expected to continue to expand in the coming years. AI, or artificial intelligence, is being increasingly utilized in the field of clinical trials to enhance various aspects of the trial process, including patient recruitment, data analysis, and drug development.One major trend in the AI in Clinical Trials market is the use of machine learning algorithms to improve patient recruitment and retention. AI algorithms can analyze large amounts of patient data and identify potential candidates for clinical trials more efficiently and accurately than traditional methods. This can help accelerate the recruitment process and ensure that trials have a diverse and representative patient population.
The global AI In Clinical Trials market size was estimated at USD 52.3 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global AI In Clinical Trials market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global AI In Clinical Trials market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the AI In Clinical Trials market.
Global AI In Clinical Trials Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Intel
The International Business Machines Corporation(IBM)
Koninklijke Philips N.V.
ConcertAl
Saama Technologies LLC
Samaa Technologies
Owkin Inc.
Numerate
Neuroute
AiCure
Ardigen
Unlearn Al
PathAl
Exscentia
Aitia Infotech Pvt Ltd.
Euretos
VeriSIM Life
Envisagenics
NURITAs
BioSymetrics
BioAge Labs lInc
Market Segmentation (by Type)
Software
Service
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Contract Research Organization
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the AI In Clinical Trials Market
Overview of the regional outlook of the AI In Clinical Trials Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI In Clinical Trials Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI In Clinical Trials, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global AI In Clinical Trials market size was estimated at USD 52.3 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global AI In Clinical Trials market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global AI In Clinical Trials market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the AI In Clinical Trials market.
Global AI In Clinical Trials Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Intel
The International Business Machines Corporation(IBM)
Koninklijke Philips N.V.
ConcertAl
Saama Technologies LLC
Samaa Technologies
Owkin Inc.
Numerate
Neuroute
AiCure
Ardigen
Unlearn Al
PathAl
Exscentia
Aitia Infotech Pvt Ltd.
Euretos
VeriSIM Life
Envisagenics
NURITAs
BioSymetrics
BioAge Labs lInc
Market Segmentation (by Type)
Software
Service
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Contract Research Organization
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the AI In Clinical Trials Market
Overview of the regional outlook of the AI In Clinical Trials Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI In Clinical Trials Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI In Clinical Trials, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of AI In Clinical Trials
1.2 Key Market Segments
1.2.1 AI In Clinical Trials Segment by Type
1.2.2 AI In Clinical Trials Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AI IN CLINICAL TRIALS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AI IN CLINICAL TRIALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global AI In Clinical Trials Product Life Cycle
3.3 Global AI In Clinical Trials Revenue Market Share by Company (2020-2025)
3.4 AI In Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 AI In Clinical Trials Market Competitive Situation and Trends
3.6.1 AI In Clinical Trials Market Concentration Rate
3.6.2 Global 5 and 10 Largest AI In Clinical Trials Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AI IN CLINICAL TRIALS VALUE CHAIN ANALYSIS
4.1 AI In Clinical Trials Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AI IN CLINICAL TRIALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global AI In Clinical Trials Market Porter's Five Forces Analysis
6 AI IN CLINICAL TRIALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AI In Clinical Trials Market by Type (2020-2025)
6.3 Global AI In Clinical Trials Market Size Growth Rate by Type (2021-2025)
7 AI IN CLINICAL TRIALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AI In Clinical Trials Market Size (M USD) by Application (2020-2025)
7.3 Global AI In Clinical Trials Market Size Growth Rate by Application (2021-2025)
8 AI IN CLINICAL TRIALS MARKET SEGMENTATION BY REGION
8.1 Global AI In Clinical Trials Market Size by Region
8.1.1 Global AI In Clinical Trials Market Size by Region
8.1.2 Global AI In Clinical Trials Market Size Market Share by Region
8.2 North America
8.2.1 North America AI In Clinical Trials Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe AI In Clinical Trials Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific AI In Clinical Trials Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America AI In Clinical Trials Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa AI In Clinical Trials Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Intel
9.1.1 Intel Basic Information
9.1.2 Intel AI In Clinical Trials Product Overview
9.1.3 Intel AI In Clinical Trials Product Market Performance
9.1.4 Intel SWOT Analysis
9.1.5 Intel Business Overview
9.1.6 Intel Recent Developments
9.2 The International Business Machines Corporation(IBM)
9.2.1 The International Business Machines Corporation(IBM) Basic Information
9.2.2 The International Business Machines Corporation(IBM) AI In Clinical Trials Product Overview
9.2.3 The International Business Machines Corporation(IBM) AI In Clinical Trials Product Market Performance
9.2.4 The International Business Machines Corporation(IBM) SWOT Analysis
9.2.5 The International Business Machines Corporation(IBM) Business Overview
9.2.6 The International Business Machines Corporation(IBM) Recent Developments
9.3 Koninklijke Philips N.V.
9.3.1 Koninklijke Philips N.V. Basic Information
9.3.2 Koninklijke Philips N.V. AI In Clinical Trials Product Overview
9.3.3 Koninklijke Philips N.V. AI In Clinical Trials Product Market Performance
9.3.4 Koninklijke Philips N.V. SWOT Analysis
9.3.5 Koninklijke Philips N.V. Business Overview
9.3.6 Koninklijke Philips N.V. Recent Developments
9.4 ConcertAl
9.4.1 ConcertAl Basic Information
9.4.2 ConcertAl AI In Clinical Trials Product Overview
9.4.3 ConcertAl AI In Clinical Trials Product Market Performance
9.4.4 ConcertAl Business Overview
9.4.5 ConcertAl Recent Developments
9.5 Saama Technologies LLC
9.5.1 Saama Technologies LLC Basic Information
9.5.2 Saama Technologies LLC AI In Clinical Trials Product Overview
9.5.3 Saama Technologies LLC AI In Clinical Trials Product Market Performance
9.5.4 Saama Technologies LLC Business Overview
9.5.5 Saama Technologies LLC Recent Developments
9.6 Samaa Technologies
9.6.1 Samaa Technologies Basic Information
9.6.2 Samaa Technologies AI In Clinical Trials Product Overview
9.6.3 Samaa Technologies AI In Clinical Trials Product Market Performance
9.6.4 Samaa Technologies Business Overview
9.6.5 Samaa Technologies Recent Developments
9.7 Owkin Inc.
9.7.1 Owkin Inc. Basic Information
9.7.2 Owkin Inc. AI In Clinical Trials Product Overview
9.7.3 Owkin Inc. AI In Clinical Trials Product Market Performance
9.7.4 Owkin Inc. Business Overview
9.7.5 Owkin Inc. Recent Developments
9.8 Numerate
9.8.1 Numerate Basic Information
9.8.2 Numerate AI In Clinical Trials Product Overview
9.8.3 Numerate AI In Clinical Trials Product Market Performance
9.8.4 Numerate Business Overview
9.8.5 Numerate Recent Developments
9.9 Neuroute
9.9.1 Neuroute Basic Information
9.9.2 Neuroute AI In Clinical Trials Product Overview
9.9.3 Neuroute AI In Clinical Trials Product Market Performance
9.9.4 Neuroute Business Overview
9.9.5 Neuroute Recent Developments
9.10 AiCure
9.10.1 AiCure Basic Information
9.10.2 AiCure AI In Clinical Trials Product Overview
9.10.3 AiCure AI In Clinical Trials Product Market Performance
9.10.4 AiCure Business Overview
9.10.5 AiCure Recent Developments
9.11 Ardigen
9.11.1 Ardigen Basic Information
9.11.2 Ardigen AI In Clinical Trials Product Overview
9.11.3 Ardigen AI In Clinical Trials Product Market Performance
9.11.4 Ardigen Business Overview
9.11.5 Ardigen Recent Developments
9.12 Unlearn Al
9.12.1 Unlearn Al Basic Information
9.12.2 Unlearn Al AI In Clinical Trials Product Overview
9.12.3 Unlearn Al AI In Clinical Trials Product Market Performance
9.12.4 Unlearn Al Business Overview
9.12.5 Unlearn Al Recent Developments
9.13 PathAl
9.13.1 PathAl Basic Information
9.13.2 PathAl AI In Clinical Trials Product Overview
9.13.3 PathAl AI In Clinical Trials Product Market Performance
9.13.4 PathAl Business Overview
9.13.5 PathAl Recent Developments
9.14 Exscentia
9.14.1 Exscentia Basic Information
9.14.2 Exscentia AI In Clinical Trials Product Overview
9.14.3 Exscentia AI In Clinical Trials Product Market Performance
9.14.4 Exscentia Business Overview
9.14.5 Exscentia Recent Developments
9.15 Aitia Infotech Pvt Ltd.
9.15.1 Aitia Infotech Pvt Ltd. Basic Information
9.15.2 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Overview
9.15.3 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Market Performance
9.15.4 Aitia Infotech Pvt Ltd. Business Overview
9.15.5 Aitia Infotech Pvt Ltd. Recent Developments
9.16 Euretos
9.16.1 Euretos Basic Information
9.16.2 Euretos AI In Clinical Trials Product Overview
9.16.3 Euretos AI In Clinical Trials Product Market Performance
9.16.4 Euretos Business Overview
9.16.5 Euretos Recent Developments
9.17 VeriSIM Life
9.17.1 VeriSIM Life Basic Information
9.17.2 VeriSIM Life AI In Clinical Trials Product Overview
9.17.3 VeriSIM Life AI In Clinical Trials Product Market Performance
9.17.4 VeriSIM Life Business Overview
9.17.5 VeriSIM Life Recent Developments
9.18 Envisagenics
9.18.1 Envisagenics Basic Information
9.18.2 Envisagenics AI In Clinical Trials Product Overview
9.18.3 Envisagenics AI In Clinical Trials Product Market Performance
9.18.4 Envisagenics Business Overview
9.18.5 Envisagenics Recent Developments
9.19 NURITAs
9.19.1 NURITAs Basic Information
9.19.2 NURITAs AI In Clinical Trials Product Overview
9.19.3 NURITAs AI In Clinical Trials Product Market Performance
9.19.4 NURITAs Business Overview
9.19.5 NURITAs Recent Developments
9.20 BioSymetrics
9.20.1 BioSymetrics Basic Information
9.20.2 BioSymetrics AI In Clinical Trials Product Overview
9.20.3 BioSymetrics AI In Clinical Trials Product Market Performance
9.20.4 BioSymetrics Business Overview
9.20.5 BioSymetrics Recent Developments
9.21 BioAge Labs lInc
9.21.1 BioAge Labs lInc Basic Information
9.21.2 BioAge Labs lInc AI In Clinical Trials Product Overview
9.21.3 BioAge Labs lInc AI In Clinical Trials Product Market Performance
9.21.4 BioAge Labs lInc Business Overview
9.21.5 BioAge Labs lInc Recent Developments
10 AI IN CLINICAL TRIALS MARKET FORECAST BY REGION
10.1 Global AI In Clinical Trials Market Size Forecast
10.2 Global AI In Clinical Trials Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe AI In Clinical Trials Market Size Forecast by Country
10.2.3 Asia Pacific AI In Clinical Trials Market Size Forecast by Region
10.2.4 South America AI In Clinical Trials Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of AI In Clinical Trials by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global AI In Clinical Trials Market Forecast by Type (2026-2035)
11.1.1 Global AI In Clinical Trials Market Size Forecast by Type (2026-2035)
11.2 Global AI In Clinical Trials Market Forecast by Application (2026-2035)
11.2.1 Global AI In Clinical Trials Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of AI In Clinical Trials
1.2 Key Market Segments
1.2.1 AI In Clinical Trials Segment by Type
1.2.2 AI In Clinical Trials Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AI IN CLINICAL TRIALS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AI IN CLINICAL TRIALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global AI In Clinical Trials Product Life Cycle
3.3 Global AI In Clinical Trials Revenue Market Share by Company (2020-2025)
3.4 AI In Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 AI In Clinical Trials Market Competitive Situation and Trends
3.6.1 AI In Clinical Trials Market Concentration Rate
3.6.2 Global 5 and 10 Largest AI In Clinical Trials Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AI IN CLINICAL TRIALS VALUE CHAIN ANALYSIS
4.1 AI In Clinical Trials Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AI IN CLINICAL TRIALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global AI In Clinical Trials Market Porter's Five Forces Analysis
6 AI IN CLINICAL TRIALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AI In Clinical Trials Market by Type (2020-2025)
6.3 Global AI In Clinical Trials Market Size Growth Rate by Type (2021-2025)
7 AI IN CLINICAL TRIALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AI In Clinical Trials Market Size (M USD) by Application (2020-2025)
7.3 Global AI In Clinical Trials Market Size Growth Rate by Application (2021-2025)
8 AI IN CLINICAL TRIALS MARKET SEGMENTATION BY REGION
8.1 Global AI In Clinical Trials Market Size by Region
8.1.1 Global AI In Clinical Trials Market Size by Region
8.1.2 Global AI In Clinical Trials Market Size Market Share by Region
8.2 North America
8.2.1 North America AI In Clinical Trials Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe AI In Clinical Trials Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific AI In Clinical Trials Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America AI In Clinical Trials Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa AI In Clinical Trials Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Intel
9.1.1 Intel Basic Information
9.1.2 Intel AI In Clinical Trials Product Overview
9.1.3 Intel AI In Clinical Trials Product Market Performance
9.1.4 Intel SWOT Analysis
9.1.5 Intel Business Overview
9.1.6 Intel Recent Developments
9.2 The International Business Machines Corporation(IBM)
9.2.1 The International Business Machines Corporation(IBM) Basic Information
9.2.2 The International Business Machines Corporation(IBM) AI In Clinical Trials Product Overview
9.2.3 The International Business Machines Corporation(IBM) AI In Clinical Trials Product Market Performance
9.2.4 The International Business Machines Corporation(IBM) SWOT Analysis
9.2.5 The International Business Machines Corporation(IBM) Business Overview
9.2.6 The International Business Machines Corporation(IBM) Recent Developments
9.3 Koninklijke Philips N.V.
9.3.1 Koninklijke Philips N.V. Basic Information
9.3.2 Koninklijke Philips N.V. AI In Clinical Trials Product Overview
9.3.3 Koninklijke Philips N.V. AI In Clinical Trials Product Market Performance
9.3.4 Koninklijke Philips N.V. SWOT Analysis
9.3.5 Koninklijke Philips N.V. Business Overview
9.3.6 Koninklijke Philips N.V. Recent Developments
9.4 ConcertAl
9.4.1 ConcertAl Basic Information
9.4.2 ConcertAl AI In Clinical Trials Product Overview
9.4.3 ConcertAl AI In Clinical Trials Product Market Performance
9.4.4 ConcertAl Business Overview
9.4.5 ConcertAl Recent Developments
9.5 Saama Technologies LLC
9.5.1 Saama Technologies LLC Basic Information
9.5.2 Saama Technologies LLC AI In Clinical Trials Product Overview
9.5.3 Saama Technologies LLC AI In Clinical Trials Product Market Performance
9.5.4 Saama Technologies LLC Business Overview
9.5.5 Saama Technologies LLC Recent Developments
9.6 Samaa Technologies
9.6.1 Samaa Technologies Basic Information
9.6.2 Samaa Technologies AI In Clinical Trials Product Overview
9.6.3 Samaa Technologies AI In Clinical Trials Product Market Performance
9.6.4 Samaa Technologies Business Overview
9.6.5 Samaa Technologies Recent Developments
9.7 Owkin Inc.
9.7.1 Owkin Inc. Basic Information
9.7.2 Owkin Inc. AI In Clinical Trials Product Overview
9.7.3 Owkin Inc. AI In Clinical Trials Product Market Performance
9.7.4 Owkin Inc. Business Overview
9.7.5 Owkin Inc. Recent Developments
9.8 Numerate
9.8.1 Numerate Basic Information
9.8.2 Numerate AI In Clinical Trials Product Overview
9.8.3 Numerate AI In Clinical Trials Product Market Performance
9.8.4 Numerate Business Overview
9.8.5 Numerate Recent Developments
9.9 Neuroute
9.9.1 Neuroute Basic Information
9.9.2 Neuroute AI In Clinical Trials Product Overview
9.9.3 Neuroute AI In Clinical Trials Product Market Performance
9.9.4 Neuroute Business Overview
9.9.5 Neuroute Recent Developments
9.10 AiCure
9.10.1 AiCure Basic Information
9.10.2 AiCure AI In Clinical Trials Product Overview
9.10.3 AiCure AI In Clinical Trials Product Market Performance
9.10.4 AiCure Business Overview
9.10.5 AiCure Recent Developments
9.11 Ardigen
9.11.1 Ardigen Basic Information
9.11.2 Ardigen AI In Clinical Trials Product Overview
9.11.3 Ardigen AI In Clinical Trials Product Market Performance
9.11.4 Ardigen Business Overview
9.11.5 Ardigen Recent Developments
9.12 Unlearn Al
9.12.1 Unlearn Al Basic Information
9.12.2 Unlearn Al AI In Clinical Trials Product Overview
9.12.3 Unlearn Al AI In Clinical Trials Product Market Performance
9.12.4 Unlearn Al Business Overview
9.12.5 Unlearn Al Recent Developments
9.13 PathAl
9.13.1 PathAl Basic Information
9.13.2 PathAl AI In Clinical Trials Product Overview
9.13.3 PathAl AI In Clinical Trials Product Market Performance
9.13.4 PathAl Business Overview
9.13.5 PathAl Recent Developments
9.14 Exscentia
9.14.1 Exscentia Basic Information
9.14.2 Exscentia AI In Clinical Trials Product Overview
9.14.3 Exscentia AI In Clinical Trials Product Market Performance
9.14.4 Exscentia Business Overview
9.14.5 Exscentia Recent Developments
9.15 Aitia Infotech Pvt Ltd.
9.15.1 Aitia Infotech Pvt Ltd. Basic Information
9.15.2 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Overview
9.15.3 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Market Performance
9.15.4 Aitia Infotech Pvt Ltd. Business Overview
9.15.5 Aitia Infotech Pvt Ltd. Recent Developments
9.16 Euretos
9.16.1 Euretos Basic Information
9.16.2 Euretos AI In Clinical Trials Product Overview
9.16.3 Euretos AI In Clinical Trials Product Market Performance
9.16.4 Euretos Business Overview
9.16.5 Euretos Recent Developments
9.17 VeriSIM Life
9.17.1 VeriSIM Life Basic Information
9.17.2 VeriSIM Life AI In Clinical Trials Product Overview
9.17.3 VeriSIM Life AI In Clinical Trials Product Market Performance
9.17.4 VeriSIM Life Business Overview
9.17.5 VeriSIM Life Recent Developments
9.18 Envisagenics
9.18.1 Envisagenics Basic Information
9.18.2 Envisagenics AI In Clinical Trials Product Overview
9.18.3 Envisagenics AI In Clinical Trials Product Market Performance
9.18.4 Envisagenics Business Overview
9.18.5 Envisagenics Recent Developments
9.19 NURITAs
9.19.1 NURITAs Basic Information
9.19.2 NURITAs AI In Clinical Trials Product Overview
9.19.3 NURITAs AI In Clinical Trials Product Market Performance
9.19.4 NURITAs Business Overview
9.19.5 NURITAs Recent Developments
9.20 BioSymetrics
9.20.1 BioSymetrics Basic Information
9.20.2 BioSymetrics AI In Clinical Trials Product Overview
9.20.3 BioSymetrics AI In Clinical Trials Product Market Performance
9.20.4 BioSymetrics Business Overview
9.20.5 BioSymetrics Recent Developments
9.21 BioAge Labs lInc
9.21.1 BioAge Labs lInc Basic Information
9.21.2 BioAge Labs lInc AI In Clinical Trials Product Overview
9.21.3 BioAge Labs lInc AI In Clinical Trials Product Market Performance
9.21.4 BioAge Labs lInc Business Overview
9.21.5 BioAge Labs lInc Recent Developments
10 AI IN CLINICAL TRIALS MARKET FORECAST BY REGION
10.1 Global AI In Clinical Trials Market Size Forecast
10.2 Global AI In Clinical Trials Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe AI In Clinical Trials Market Size Forecast by Country
10.2.3 Asia Pacific AI In Clinical Trials Market Size Forecast by Region
10.2.4 South America AI In Clinical Trials Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of AI In Clinical Trials by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global AI In Clinical Trials Market Forecast by Type (2026-2035)
11.1.1 Global AI In Clinical Trials Market Size Forecast by Type (2026-2035)
11.2 Global AI In Clinical Trials Market Forecast by Application (2026-2035)
11.2.1 Global AI In Clinical Trials Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global AI In Clinical Trials Market Size by Type (M USD)
Table 4. Global AI In Clinical Trials Market Size by Application
Table 5. AI In Clinical Trials Market Size Comparison by Region (M USD)
Table 6. Global AI In Clinical Trials Revenue (M USD) by Company (2020-2025)
Table 7. Global AI In Clinical Trials Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Clinical Trials as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global AI In Clinical Trials Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. AI In Clinical Trials Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global AI In Clinical Trials Market Size by Type (M USD)
Table 22. Global AI In Clinical Trials Market Size (M USD) by Type (2020-2025)
Table 23. Global AI In Clinical Trials Market Share by Type (2020-2025)
Table 24. Global AI In Clinical Trials Market Size Growth Rate by Type (2021-2025)
Table 25. Global AI In Clinical Trials Market Size by Application
Table 26. Global AI In Clinical Trials Market Size by Application (2020-2025) & (M USD)
Table 27. Global AI In Clinical Trials Market Share by Application (2020-2025)
Table 28. Global AI In Clinical Trials Market Size Growth Rate by Application (2021-2025)
Table 29. Global AI In Clinical Trials Market Size by Region (2020-2025) & (M USD)
Table 30. Global AI In Clinical Trials Market Size Market Share by Region (2020-2025)
Table 31. North America AI In Clinical Trials Market Size by Country (2020-2025) & (M USD)
Table 32. Europe AI In Clinical Trials Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific AI In Clinical Trials Market Size by Region (2020-2025) & (M USD)
Table 34. South America AI In Clinical Trials Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa AI In Clinical Trials Market Size by Region (2020-2025) & (M USD)
Table 36. Intel Basic Information
Table 37. Intel AI In Clinical Trials Product Overview
Table 38. Intel AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Intel SWOT Analysis
Table 40. Intel Business Overview
Table 41. Intel Recent Developments
Table 42. The International Business Machines Corporation(IBM) Basic Information
Table 43. The International Business Machines Corporation(IBM) AI In Clinical Trials Product Overview
Table 44. The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 45. The International Business Machines Corporation(IBM) SWOT Analysis
Table 46. The International Business Machines Corporation(IBM) Business Overview
Table 47. The International Business Machines Corporation(IBM) Recent Developments
Table 48. Koninklijke Philips N.V. Basic Information
Table 49. Koninklijke Philips N.V. AI In Clinical Trials Product Overview
Table 50. Koninklijke Philips N.V. AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Koninklijke Philips N.V. SWOT Analysis
Table 52. Koninklijke Philips N.V. Business Overview
Table 53. Koninklijke Philips N.V. Recent Developments
Table 54. ConcertAl Basic Information
Table 55. ConcertAl AI In Clinical Trials Product Overview
Table 56. ConcertAl AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 57. ConcertAl Business Overview
Table 58. ConcertAl Recent Developments
Table 59. Saama Technologies LLC Basic Information
Table 60. Saama Technologies LLC AI In Clinical Trials Product Overview
Table 61. Saama Technologies LLC AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Saama Technologies LLC Business Overview
Table 63. Saama Technologies LLC Recent Developments
Table 64. Samaa Technologies Basic Information
Table 65. Samaa Technologies AI In Clinical Trials Product Overview
Table 66. Samaa Technologies AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Samaa Technologies Business Overview
Table 68. Samaa Technologies Recent Developments
Table 69. Owkin Inc. Basic Information
Table 70. Owkin Inc. AI In Clinical Trials Product Overview
Table 71. Owkin Inc. AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Owkin Inc. Business Overview
Table 73. Owkin Inc. Recent Developments
Table 74. Numerate Basic Information
Table 75. Numerate AI In Clinical Trials Product Overview
Table 76. Numerate AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Numerate Business Overview
Table 78. Numerate Recent Developments
Table 79. Neuroute Basic Information
Table 80. Neuroute AI In Clinical Trials Product Overview
Table 81. Neuroute AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Neuroute Business Overview
Table 83. Neuroute Recent Developments
Table 84. AiCure Basic Information
Table 85. AiCure AI In Clinical Trials Product Overview
Table 86. AiCure AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 87. AiCure Business Overview
Table 88. AiCure Recent Developments
Table 89. Ardigen Basic Information
Table 90. Ardigen AI In Clinical Trials Product Overview
Table 91. Ardigen AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Ardigen Business Overview
Table 93. Ardigen Recent Developments
Table 94. Unlearn Al Basic Information
Table 95. Unlearn Al AI In Clinical Trials Product Overview
Table 96. Unlearn Al AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Unlearn Al Business Overview
Table 98. Unlearn Al Recent Developments
Table 99. PathAl Basic Information
Table 100. PathAl AI In Clinical Trials Product Overview
Table 101. PathAl AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 102. PathAl Business Overview
Table 103. PathAl Recent Developments
Table 104. Exscentia Basic Information
Table 105. Exscentia AI In Clinical Trials Product Overview
Table 106. Exscentia AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Exscentia Business Overview
Table 108. Exscentia Recent Developments
Table 109. Aitia Infotech Pvt Ltd. Basic Information
Table 110. Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Overview
Table 111. Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Aitia Infotech Pvt Ltd. Business Overview
Table 113. Aitia Infotech Pvt Ltd. Recent Developments
Table 114. Euretos Basic Information
Table 115. Euretos AI In Clinical Trials Product Overview
Table 116. Euretos AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Euretos Business Overview
Table 118. Euretos Recent Developments
Table 119. VeriSIM Life Basic Information
Table 120. VeriSIM Life AI In Clinical Trials Product Overview
Table 121. VeriSIM Life AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 122. VeriSIM Life Business Overview
Table 123. VeriSIM Life Recent Developments
Table 124. Envisagenics Basic Information
Table 125. Envisagenics AI In Clinical Trials Product Overview
Table 126. Envisagenics AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Envisagenics Business Overview
Table 128. Envisagenics Recent Developments
Table 129. NURITAs Basic Information
Table 130. NURITAs AI In Clinical Trials Product Overview
Table 131. NURITAs AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 132. NURITAs Business Overview
Table 133. NURITAs Recent Developments
Table 134. BioSymetrics Basic Information
Table 135. BioSymetrics AI In Clinical Trials Product Overview
Table 136. BioSymetrics AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 137. BioSymetrics Business Overview
Table 138. BioSymetrics Recent Developments
Table 139. BioAge Labs lInc Basic Information
Table 140. BioAge Labs lInc AI In Clinical Trials Product Overview
Table 141. BioAge Labs lInc AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 142. BioAge Labs lInc Business Overview
Table 143. BioAge Labs lInc Recent Developments
Table 144. Global AI In Clinical Trials Market Size Forecast by Region (2026-2035) & (M USD)
Table 145. North America AI In Clinical Trials Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Europe AI In Clinical Trials Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Asia Pacific AI In Clinical Trials Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America AI In Clinical Trials Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Middle East and Africa AI In Clinical Trials Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Global AI In Clinical Trials Market Size Forecast by Type (2026-2035) & (M USD)
Table 151. Global AI In Clinical Trials Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global AI In Clinical Trials Market Size by Type (M USD)
Table 4. Global AI In Clinical Trials Market Size by Application
Table 5. AI In Clinical Trials Market Size Comparison by Region (M USD)
Table 6. Global AI In Clinical Trials Revenue (M USD) by Company (2020-2025)
Table 7. Global AI In Clinical Trials Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Clinical Trials as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global AI In Clinical Trials Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. AI In Clinical Trials Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global AI In Clinical Trials Market Size by Type (M USD)
Table 22. Global AI In Clinical Trials Market Size (M USD) by Type (2020-2025)
Table 23. Global AI In Clinical Trials Market Share by Type (2020-2025)
Table 24. Global AI In Clinical Trials Market Size Growth Rate by Type (2021-2025)
Table 25. Global AI In Clinical Trials Market Size by Application
Table 26. Global AI In Clinical Trials Market Size by Application (2020-2025) & (M USD)
Table 27. Global AI In Clinical Trials Market Share by Application (2020-2025)
Table 28. Global AI In Clinical Trials Market Size Growth Rate by Application (2021-2025)
Table 29. Global AI In Clinical Trials Market Size by Region (2020-2025) & (M USD)
Table 30. Global AI In Clinical Trials Market Size Market Share by Region (2020-2025)
Table 31. North America AI In Clinical Trials Market Size by Country (2020-2025) & (M USD)
Table 32. Europe AI In Clinical Trials Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific AI In Clinical Trials Market Size by Region (2020-2025) & (M USD)
Table 34. South America AI In Clinical Trials Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa AI In Clinical Trials Market Size by Region (2020-2025) & (M USD)
Table 36. Intel Basic Information
Table 37. Intel AI In Clinical Trials Product Overview
Table 38. Intel AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Intel SWOT Analysis
Table 40. Intel Business Overview
Table 41. Intel Recent Developments
Table 42. The International Business Machines Corporation(IBM) Basic Information
Table 43. The International Business Machines Corporation(IBM) AI In Clinical Trials Product Overview
Table 44. The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 45. The International Business Machines Corporation(IBM) SWOT Analysis
Table 46. The International Business Machines Corporation(IBM) Business Overview
Table 47. The International Business Machines Corporation(IBM) Recent Developments
Table 48. Koninklijke Philips N.V. Basic Information
Table 49. Koninklijke Philips N.V. AI In Clinical Trials Product Overview
Table 50. Koninklijke Philips N.V. AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Koninklijke Philips N.V. SWOT Analysis
Table 52. Koninklijke Philips N.V. Business Overview
Table 53. Koninklijke Philips N.V. Recent Developments
Table 54. ConcertAl Basic Information
Table 55. ConcertAl AI In Clinical Trials Product Overview
Table 56. ConcertAl AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 57. ConcertAl Business Overview
Table 58. ConcertAl Recent Developments
Table 59. Saama Technologies LLC Basic Information
Table 60. Saama Technologies LLC AI In Clinical Trials Product Overview
Table 61. Saama Technologies LLC AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Saama Technologies LLC Business Overview
Table 63. Saama Technologies LLC Recent Developments
Table 64. Samaa Technologies Basic Information
Table 65. Samaa Technologies AI In Clinical Trials Product Overview
Table 66. Samaa Technologies AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Samaa Technologies Business Overview
Table 68. Samaa Technologies Recent Developments
Table 69. Owkin Inc. Basic Information
Table 70. Owkin Inc. AI In Clinical Trials Product Overview
Table 71. Owkin Inc. AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Owkin Inc. Business Overview
Table 73. Owkin Inc. Recent Developments
Table 74. Numerate Basic Information
Table 75. Numerate AI In Clinical Trials Product Overview
Table 76. Numerate AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Numerate Business Overview
Table 78. Numerate Recent Developments
Table 79. Neuroute Basic Information
Table 80. Neuroute AI In Clinical Trials Product Overview
Table 81. Neuroute AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Neuroute Business Overview
Table 83. Neuroute Recent Developments
Table 84. AiCure Basic Information
Table 85. AiCure AI In Clinical Trials Product Overview
Table 86. AiCure AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 87. AiCure Business Overview
Table 88. AiCure Recent Developments
Table 89. Ardigen Basic Information
Table 90. Ardigen AI In Clinical Trials Product Overview
Table 91. Ardigen AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Ardigen Business Overview
Table 93. Ardigen Recent Developments
Table 94. Unlearn Al Basic Information
Table 95. Unlearn Al AI In Clinical Trials Product Overview
Table 96. Unlearn Al AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Unlearn Al Business Overview
Table 98. Unlearn Al Recent Developments
Table 99. PathAl Basic Information
Table 100. PathAl AI In Clinical Trials Product Overview
Table 101. PathAl AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 102. PathAl Business Overview
Table 103. PathAl Recent Developments
Table 104. Exscentia Basic Information
Table 105. Exscentia AI In Clinical Trials Product Overview
Table 106. Exscentia AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Exscentia Business Overview
Table 108. Exscentia Recent Developments
Table 109. Aitia Infotech Pvt Ltd. Basic Information
Table 110. Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Overview
Table 111. Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Aitia Infotech Pvt Ltd. Business Overview
Table 113. Aitia Infotech Pvt Ltd. Recent Developments
Table 114. Euretos Basic Information
Table 115. Euretos AI In Clinical Trials Product Overview
Table 116. Euretos AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Euretos Business Overview
Table 118. Euretos Recent Developments
Table 119. VeriSIM Life Basic Information
Table 120. VeriSIM Life AI In Clinical Trials Product Overview
Table 121. VeriSIM Life AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 122. VeriSIM Life Business Overview
Table 123. VeriSIM Life Recent Developments
Table 124. Envisagenics Basic Information
Table 125. Envisagenics AI In Clinical Trials Product Overview
Table 126. Envisagenics AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Envisagenics Business Overview
Table 128. Envisagenics Recent Developments
Table 129. NURITAs Basic Information
Table 130. NURITAs AI In Clinical Trials Product Overview
Table 131. NURITAs AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 132. NURITAs Business Overview
Table 133. NURITAs Recent Developments
Table 134. BioSymetrics Basic Information
Table 135. BioSymetrics AI In Clinical Trials Product Overview
Table 136. BioSymetrics AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 137. BioSymetrics Business Overview
Table 138. BioSymetrics Recent Developments
Table 139. BioAge Labs lInc Basic Information
Table 140. BioAge Labs lInc AI In Clinical Trials Product Overview
Table 141. BioAge Labs lInc AI In Clinical Trials Revenue (M USD) and Gross Margin (2020-2025)
Table 142. BioAge Labs lInc Business Overview
Table 143. BioAge Labs lInc Recent Developments
Table 144. Global AI In Clinical Trials Market Size Forecast by Region (2026-2035) & (M USD)
Table 145. North America AI In Clinical Trials Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Europe AI In Clinical Trials Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Asia Pacific AI In Clinical Trials Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America AI In Clinical Trials Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Middle East and Africa AI In Clinical Trials Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Global AI In Clinical Trials Market Size Forecast by Type (2026-2035) & (M USD)
Table 151. Global AI In Clinical Trials Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of AI In Clinical Trials
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AI In Clinical Trials Market Size (M USD), 2025-2035
Figure 5. Global AI In Clinical Trials Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. AI In Clinical Trials Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global AI In Clinical Trials Product Life Cycle
Figure 12. Global AI In Clinical Trials Revenue Share by Company in 2025
Figure 13. AI In Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by AI In Clinical Trials Revenue in 2025
Figure 15. Value Chain Map of AI In Clinical Trials
Figure 16. Global AI In Clinical Trials Market PEST Analysis
Figure 17. Global AI In Clinical Trials Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global AI In Clinical Trials Market Share by Type
Figure 20. Market Share of AI In Clinical Trials by Type (2020-2025)
Figure 21. Global AI In Clinical Trials Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global AI In Clinical Trials Market Share by Application
Figure 24. Global AI In Clinical Trials Market Share by Application (2020-2025)
Figure 25. Global AI In Clinical Trials Market Share by Application in 2024
Figure 26. Global AI In Clinical Trials Market Size Growth Rate by Application (2021-2025)
Figure 27. Global AI In Clinical Trials Market Size Market Share by Region (2020-2025)
Figure 28. North America AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America AI In Clinical Trials Market Size Market Share by Country in 2024
Figure 30. U.S. AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada AI In Clinical Trials Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico AI In Clinical Trials Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe AI In Clinical Trials Market Share by Country in 2024
Figure 35. Germany AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific AI In Clinical Trials Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific AI In Clinical Trials Market Size Market Share by Region in 2024
Figure 42. China AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America AI In Clinical Trials Market Size and Growth Rate (M USD)
Figure 48. South America AI In Clinical Trials Market Size Market Share by Country in 2024
Figure 49. Brazil AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa AI In Clinical Trials Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa AI In Clinical Trials Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global AI In Clinical Trials Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global AI In Clinical Trials Market Share Forecast by Type (2026-2035)
Figure 61. Global AI In Clinical Trials Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of AI In Clinical Trials
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AI In Clinical Trials Market Size (M USD), 2025-2035
Figure 5. Global AI In Clinical Trials Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. AI In Clinical Trials Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global AI In Clinical Trials Product Life Cycle
Figure 12. Global AI In Clinical Trials Revenue Share by Company in 2025
Figure 13. AI In Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by AI In Clinical Trials Revenue in 2025
Figure 15. Value Chain Map of AI In Clinical Trials
Figure 16. Global AI In Clinical Trials Market PEST Analysis
Figure 17. Global AI In Clinical Trials Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global AI In Clinical Trials Market Share by Type
Figure 20. Market Share of AI In Clinical Trials by Type (2020-2025)
Figure 21. Global AI In Clinical Trials Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global AI In Clinical Trials Market Share by Application
Figure 24. Global AI In Clinical Trials Market Share by Application (2020-2025)
Figure 25. Global AI In Clinical Trials Market Share by Application in 2024
Figure 26. Global AI In Clinical Trials Market Size Growth Rate by Application (2021-2025)
Figure 27. Global AI In Clinical Trials Market Size Market Share by Region (2020-2025)
Figure 28. North America AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America AI In Clinical Trials Market Size Market Share by Country in 2024
Figure 30. U.S. AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada AI In Clinical Trials Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico AI In Clinical Trials Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe AI In Clinical Trials Market Share by Country in 2024
Figure 35. Germany AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific AI In Clinical Trials Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific AI In Clinical Trials Market Size Market Share by Region in 2024
Figure 42. China AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America AI In Clinical Trials Market Size and Growth Rate (M USD)
Figure 48. South America AI In Clinical Trials Market Size Market Share by Country in 2024
Figure 49. Brazil AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa AI In Clinical Trials Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa AI In Clinical Trials Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa AI In Clinical Trials Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global AI In Clinical Trials Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global AI In Clinical Trials Market Share Forecast by Type (2026-2035)
Figure 61. Global AI In Clinical Trials Market Share Forecast by Application (2026-2035)
